Rhabdomyolysis in human immunodeficiency virus--positive patients taking trimethoprim-sulfamethoxazole.
Singer
S J
SJ
U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, Maryland, USA.
Racoosin
J A
JA
Viraraghavan
R
R
D000328:Adult; D000890:Anti-Infective Agents / Q000009:adverse effects*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012206:Rhabdomyolysis / Q000139:chemically induced*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects*
D000890:Anti-Infective Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination